Gene: PDE3B
Official Full Name: phosphodiesterase 3Bprovided by HGNC
Gene Summary: Enables 3',5'-cyclic-AMP phosphodiesterase activity. Involved in several processes, including negative regulation of angiogenesis; negative regulation of lipid catabolic process; and regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08427 | PDE3B Knockout cell line (HeLa) | Human | PDE3B | 1:3~1:6 | Negative | Online Inquiry |
KO08428 | PDE3B Knockout cell line (HCT 116) | Human | PDE3B | 1:2~1:4 | Negative | Online Inquiry |
KO08429 | PDE3B Knockout cell line (HEK293) | Human | PDE3B | 1:3~1:6 | Negative | Online Inquiry |
KO08430 | PDE3B Knockout cell line (A549) | Human | PDE3B | 1:3~1:4 | Negative | Online Inquiry |
PDE3B Gene Knockout Cell Lines are sophisticated biological research tools designed for the study of the phosphodiesterase 3B (PDE3B) gene, which plays a crucial role in cellular signaling and metabolic processes. These cell lines are genetically engineered to have the PDE3B gene inactivated, allowing scientists to investigate the functional consequences of PDE3B deficiency in various physiological and pathological contexts.
The core function of PDE3B involves the hydrolysis of cyclic AMP (cAMP) and cyclic GMP (cGMP), two critical second messengers that regulate a myriad of cellular pathways, including lipolysis, insulin signaling, and cell proliferation. By knocking out the PDE3B gene, researchers can directly observe the alterations in cAMP/cGMP levels and associated signaling pathways, providing invaluable insights into the mechanisms underlying metabolic disorders, cardiovascular diseases, and diabetes.
The scientific importance of PDE3B Gene Knockout Cell Lines lies in their versatile applications in both basic research and therapeutic development. In preclinical studies, these cell lines facilitate the identification of drug targets and the exploration of new treatments. Additionally, understanding the role of PDE3B in various disease models can help elucidate complex pathological mechanisms, paving the way for novel interventions in clinical settings.
One of the standout features of our PDE3B Gene Knockout Cell Lines is their high specificity and reliability compared to conventional methods such as pharmacological inhibition, which can lead to off-target effects. Furthermore, our product ensures consistent and reproducible results, which are critical for generating reliable data in research.
These cell lines are indispensable for researchers and clinicians striving to develop targeted therapies and deepen their understanding of PDE3B's role in health and disease. By choosing our PDE3B Gene Knockout Cell Lines, you are investing in a powerful tool backed by our company’s extensive expertise in genetic engineering and commitment to advancing biological research. Our dedication to quality ensures you receive a product that is not only scientifically sound but also fosters groundbreaking discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.